Concord Biotech fundamental analysis
CONCORDBIO
1347.7
3.80 (0.28%)Last updated on 24 Dec, 2025 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Concord Biotech Fundamentals
P/E Ratio
43.31
P/B Ratio
7.68
Div. Yield
0.8
Sector P/E
71.29
Sector P/B
1.09
Sec. Div. Yield
0.56
Concord Biotech Fundamentals is currently trading with a P/E Ratio of 43.31, compared to the sector average of 71.29. Its P/B Ratio stands at 7.68, while the sector’s is 1.09. In terms of returns, the stock offers a Dividend Yield of 0.8%, which is than the sector’s 0.56%.
Concord Biotech Score Card
Price
Attractive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Concord Biotech reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
